These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8052141

  • 1. Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis.
    Salen G, Batta AK, Tint GS, Shefer S.
    Metabolism; 1994 Aug; 43(8):1018-22. PubMed ID: 8052141
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
    Batta AK, Salen G, Tint GS.
    Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
    [Abstract] [Full Text] [Related]

  • 5. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G, Berginer V, Shore V, Horak I, Horak E, Tint GS, Shefer S.
    N Engl J Med; 1987 May 14; 316(20):1233-8. PubMed ID: 3106810
    [Abstract] [Full Text] [Related]

  • 6. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
    Kuriyama M, Tokimura Y, Fujiyama J, Utatsu Y, Osame M.
    J Neurol Sci; 1994 Aug 14; 125(1):22-8. PubMed ID: 7964884
    [Abstract] [Full Text] [Related]

  • 7. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
    Kuriyama M, Fujiyama J, Kasama T, Osame M.
    J Lipid Res; 1991 Feb 14; 32(2):223-9. PubMed ID: 2066659
    [Abstract] [Full Text] [Related]

  • 8. Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy.
    Watts GF, Mitchell WD, Bending JJ, Reshef A, Leitersdorf E.
    QJM; 1996 Jan 14; 89(1):55-63. PubMed ID: 8730343
    [Abstract] [Full Text] [Related]

  • 9. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
    Batta AK, Shefer S, Batta M, Salen G.
    J Lipid Res; 1985 Jun 14; 26(6):690-8. PubMed ID: 4031647
    [Abstract] [Full Text] [Related]

  • 10. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug 14; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 11. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Waterreus RJ, Oosterhuis HJ.
    Clin Chim Acta; 1984 Sep 15; 142(1):103-11. PubMed ID: 6478619
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
    Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ.
    Clin Chim Acta; 1983 Jun 30; 131(1-2):53-65. PubMed ID: 6883710
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
    Wolthers BG, van der Molen JC, Walrecht H, Hesselmans LF.
    Clin Chim Acta; 1990 Dec 14; 193(3):113-8. PubMed ID: 2282689
    [Abstract] [Full Text] [Related]

  • 16. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G, Shefer S, Tint GS, Nicolau G, Dayal B, Batta AK.
    J Clin Invest; 1985 Aug 14; 76(2):744-51. PubMed ID: 4031069
    [Abstract] [Full Text] [Related]

  • 17. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
    DeBarber AE, Schaefer EJ, Do J, Ray JW, Larson A, Redder S, Fowler M, Duell PB.
    J Clin Lipidol; 2024 Aug 14; 18(3):e465-e476. PubMed ID: 38637260
    [Abstract] [Full Text] [Related]

  • 18. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Grundy SM.
    J Clin Invest; 1973 Nov 14; 52(11):2822-35. PubMed ID: 4355999
    [Abstract] [Full Text] [Related]

  • 19. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ, Lindenthal B, Dotti MT, Federico A, Kelleher JK, von Bergmann K.
    Metabolism; 2005 Mar 14; 54(3):335-44. PubMed ID: 15736111
    [Abstract] [Full Text] [Related]

  • 20. Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX.
    de Sain-van der Velden MG, Verrips A, Prinsen BH, de Barse M, Berger R, Visser G.
    J Inherit Metab Dis; 2008 Dec 14; 31 Suppl 2():S387-93. PubMed ID: 18949577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.